Vivienne Aghogho Ayomanor, NP
NPI 1790282960ActiveIndividual· Clinical Nurse Specialist, Psych/Mental Health, Child & Family· Los Angeles, CA
Clinical Nurse Specialist, Psych/Mental Health, Child & Family (NP) with St. John's Community Health, practicing in Los Angeles, California. Part D covered 210 prescriptions written in 2024, 91% of them generic. Janssen Pharmaceuticals, Inc was the largest of 5 companies reporting payments in 2025, $1,118 in all, mostly food and beverage.
Overview
| NPI | 1790282960 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | NP |
| Sole proprietor | Yes |
| NPI issued | Apr 12, 2018 |
| Last updated in NPPES | Oct 30, 2025 |
| Certified by provider | Oct 30, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Clinical Nurse Specialist, Psych/Mental Health, Child & Family Primary | 364SP0810X | 2022002084 | CA |
| Nurse Practitioner, Family | 363LF0000X | F03180872 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Nurse Practitioner (CA) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 210 · 262 30-day fills |
|---|---|
| Patients | 42 |
| Total drug cost | $57,306 |
| Generic share | 91% of claims |
Education and affiliations
| Graduation year | 2017 |
|---|---|
| Medicare specialty | Nurse Practitioner |
Medical group
- St. John's Community HealthSan Jacinto, CA · 158 clinicians
Industry payments (Open Payments)
- 2025$1,118 · 16 payments from 5 companies
- 2024$2,698 · 36 payments from 11 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Janssen Pharmaceuticals, Inc | $749.71 | 10 |
| Teva Pharmaceuticals USA, Inc. | $174.36 | 2 |
| Otsuka America Pharmaceutical, Inc. | $113.42 | 1 |
| Indivior Inc. | $67.29 | 2 |
| Gilead Sciences, Inc. | $13.58 | 1 |
What the 2025 payments were for
- Food and Beverage$1,118 · 16 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records